Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that it will be hosting a complimentary webinar with Eric S. Kastango, M.B.A., B.S.Pharm., FASHP on "The Current State of Compounding Standards: What Happens Next?"
Kastango will explore and review the activity of USP Chapter 797, 800 and the requirements associated with the Drug Quality and Security Act. During the webinar, Kastango will also review the next steps following the May 31 closure of the public comment period for the proposed USP Chapter <800>, as well as when the final HD chapter might be release. He will also review the activity of the FDA, the registration of 503B Outsourcing Facilities, FDA Form 483 activity and new draft guidance on the compounding of biologics and repackaging.
Date: Wednesday, June 24, 2014
Time: 1:00 PM - 2:00 PM ET
Kastango is president of Clinical IQ LLC, a healthcare consulting firm, and CriticalPoint, LLC, a web-based education company. He received his Bachelor of Science degree in pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences and his Master of Business Administration degree from the University of Phoenix. Kastango is one of four recipients of the 2013 Outstanding Service Award from the Massachusetts Society of Health-System Pharmacists and the 2014 recipient of the NABP Henry Cade Memorial Award that recognized his efforts and assistance to the states and NABP to address the compounding tragedy that occurred in 2012.
An active member and Fellow of the American Society of Healthcare Pharmacists, Kastango also served on the USP Sterile Compounding Committee from 2005-2010 and 2010-2015 USP Council of Experts, Compounding Expert Committee until April 2013. He is currently an Expert Consultant to the USP and is actively working with NABP and state boards of pharmacy to provide training to their sterile compounding inspectors.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.